Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125534671 | 12553467 | 1 | I | 20151015 | 20151027 | 20160713 | 20160713 | PER | US-PERRIGO-15US011323 | PERRIGO | 76.75 | YR | M | Y | 72.56000 | KG | 20160713 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125534671 | 12553467 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, QD | 195 | MG | Y | 5HE1207 | 202319 | 15 | MG | MODIFIED-RELEASE CAPSULE, HARD | |||
| 125534671 | 12553467 | 2 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534671 | 12553467 | 3 | C | Senior multivitamin | 2 | Unknown | UNK | U | UNKNOWN | 0 | |||||||||
| 125534671 | 12553467 | 4 | C | TAMSULOSIN | TAMSULOSIN | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 125534671 | 12553467 | 5 | C | ECHINACEA /01323501/ | 2 | Unknown | UNK | U | UNKNOWN | 0 | |||||||||
| 125534671 | 12553467 | 6 | C | VITAMIN E /00110501/ | TOCOPHEROL | 1 | Unknown | 400 MG, QD | U | UNKNOWN | 0 | 400 | MG | ||||||
| 125534671 | 12553467 | 7 | C | FISH OIL | FISH OIL | 1 | Unknown | 1200 MG, QD | U | UNKNOWN | 0 | 1200 | MG | ||||||
| 125534671 | 12553467 | 8 | C | L-LYSINE /00919901/ | 2 | Unknown | 500 MG, QD | U | UNKNOWN | 0 | 500 | MG | |||||||
| 125534671 | 12553467 | 9 | C | BAYER ASPIRIN REGIMEN | 2 | Unknown | 162 MG, QD | U | UNKNOWN | 0 | 162 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125534671 | 12553467 | 1 | Dyspepsia |
| 125534671 | 12553467 | 2 | Blood cholesterol increased |
| 125534671 | 12553467 | 3 | Routine health maintenance |
| 125534671 | 12553467 | 4 | Prostatomegaly |
| 125534671 | 12553467 | 5 | Routine health maintenance |
| 125534671 | 12553467 | 6 | Routine health maintenance |
| 125534671 | 12553467 | 7 | Routine health maintenance |
| 125534671 | 12553467 | 8 | Routine health maintenance |
| 125534671 | 12553467 | 9 | Prophylaxis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125534671 | 12553467 | Diarrhoea | |
| 125534671 | 12553467 | Incorrect drug administration duration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125534671 | 12553467 | 1 | 20151003 | 20151026 | 0 | |
| 125534671 | 12553467 | 2 | 2000 | 0 | ||
| 125534671 | 12553467 | 3 | 2000 | 0 | ||
| 125534671 | 12553467 | 4 | 2012 | 0 | ||
| 125534671 | 12553467 | 9 | 1992 | 0 |